Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer
Clinical trial NCT02243007 · TERMINATED
Trial details
- NCT number
- NCT02243007
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-06-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.